Connor, Clark & Lunn Investment Management (CC&L)’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$729K Buy
277,183
+239,462
+635% +$564K ﹤0.01% 1229
2025
Q4
$72K Buy
+37,721
New +$89.4K ﹤0.01% 1494
2024
Q2
Sell
-174,356
Closed -$1.42M 1408
2024
Q1
$1.42M Buy
174,356
+6,138
+4% +$47.6K 0.01% 781
2023
Q4
$950K Buy
168,218
+3,496
+2% +$7.97K ﹤0.01% 876
2023
Q3
$306K Sell
164,722
-9,637
-6% -$29.4K ﹤0.01% 1139
2023
Q2
$479K Buy
174,359
+60,466
+53% +$194K ﹤0.01% 992
2023
Q1
$358K Buy
113,893
+99,436
+688% +$585K ﹤0.01% 972
2022
Q4
$85.3K Buy
+14,457
New +$120K ﹤0.01% 1119

Other funds holding CCCC